KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Net LoansChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Free Cash Flow (2016 - 2025)

Healthpeak Properties (DOC) has disclosed Free Cash Flow for 17 consecutive years, with $77.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 9.24% to $77.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $488.3 million, a 3.23% increase, with the full-year FY2025 number at $488.3 million, up 3.23% from a year prior.
  • Free Cash Flow was $77.5 million for Q4 2025 at Healthpeak Properties, down from $92.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $255.5 million in Q2 2022 to a low of -$37.9 million in Q4 2022.
  • A 5-year average of $88.8 million and a median of $84.0 million in 2023 define the central range for Free Cash Flow.
  • Biggest YoY gain for Free Cash Flow was 1639.55% in 2022; the steepest drop was 186.35% in 2022.
  • Healthpeak Properties' Free Cash Flow stood at $43.9 million in 2021, then plummeted by 186.35% to -$37.9 million in 2022, then surged by 317.9% to $82.5 million in 2023, then grew by 3.48% to $85.4 million in 2024, then decreased by 9.24% to $77.5 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Free Cash Flow are $77.5 million (Q4 2025), $92.2 million (Q3 2025), and $205.2 million (Q2 2025).